logo-loader

e-Therapeutics plc

Receive alerts
Market:
AIM
Market Cap:
£6.72 m
Price
2.50 GBX
Change
-1.96%
52 weeks high
7.25
52 weeks low
1.40

In brief

We are an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology. 

Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.

Deep dive We explore the investor case for growth companies

Snapshot

  • Network-driven platform helps expedite drug discovery process
  • Denmark's Novo Nordisk uses platform in search for new diabetes drugs
  • Two cancer programmes of its own
  • £5.2mln in the bank at the end of July